Skip to main content
Clinical Trials/NL-OMON52306
NL-OMON52306
Completed
Not Applicable

Observational study to investigate incidence and aetiology of viral respiratory infections in young adults who are sharing housing with other young adults during the peak 2021/22 common cold season in the Netherlands. - Viral respiratory infections in adults

eyden Labs BV0 sites104 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
common cold
Sponsor
eyden Labs BV
Enrollment
104
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
eyden Labs BV

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria (applicable to all participants in the study, including
  • housemates who only participate in contact visits)
  • 1\. Male or female, 18\-40 years of age (inclusive) at screening;
  • 2\. Living in a shared household that include at least 4 adults within the age
  • range of 18\-40 years old, of whom at least 2 will be participating in the study
  • 3\. Sharing common spaces in the house, such as kitchen, living room, bathroom,
  • etc. with household members mentioned above
  • 4\. Agreeing to sign the study informed consent form prior to any study\-related
  • procedure indicating that he or she understands the purpose, procedures and
  • potential risks, and is willing to participate in the study;

Exclusion Criteria

  • Exclusion criteria (applicable to participants who will take part in the whole
  • study, but not to those who only take part in contact visits)
  • 1\. Received or plans to receive the 2021/22 seasonal flu vaccine during the
  • study period;
  • 2\. Received COVID\-19 vaccines 14 days or less before screening or during the
  • study (COVID\-19 vaccine boosters during the study are allowed);
  • 3\. Is not protected against SARS\-CoV\-2 infection during the whole study period.
  • In line with the National Institute for Public Health and Environment (RIVM in
  • Dutch) guidance, a person is considered to be protected against COVID\-19 if one
  • or more of the following applies:

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Viral respiratory infections in young adults who are sharing housing with other young adults during the peak 2021/2022 common cold season in the NetherlandsViral respiratory infections in adults.Infections and Infestations
ISRCTN71579301eyden Laboratories B.V.104
Active, not recruiting
Not Applicable
An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly - EPI-FLUAS25-002Immunization against influenza in male and female subjects aged 50 years and over
EUCTR2006-002897-23-DEGlaxoSmithKline Biologicals3,000
Completed
Not Applicable
A study to evaluate incidences of signs and symptoms mentioned as per ayurveda under Raktavaha Srotas (Channel) in patients having recurrent mouth ulcers (Mukhpak).Health Condition 1: K120- Recurrent oral aphthae
CTRI/2019/07/020095Pradnya Dnyaneshwar Bharati65
Recruiting
Not Applicable
Incidence of Her 2 testing on pathology of patients with gastric cancerHealth Condition 1: null- gastric cancer
CTRI/2013/03/003461Tata Memorial centre100
Not yet recruiting
Not Applicable
Study to find out how often is a low body temperature seen during planned (not emergency) oesophagectomy (removal of part or whole of oesophagus) surgery with possible causes and effects leading to the same in a tertiary care (speciality)hospitalHealth Condition 1: C159- Malignant neoplasm of esophagus, unspecified
CTRI/2021/12/038675TAAT MEMORIAL CENTRE